Give Young Women Data, Not Guidelines, Advisors Tell NCI; consensus For Over 50
In Brief: Clinton Signs FY95 Apparitions Into Law, to Seek $12 Billion Recision; NIH CUTS Likely
HHS Hearings to Form National Breast Cancer Strategy. Shalala Says
Wyden Plans Bill To Induce Drug Firms to conduct Trials
DCT board Okays Recompetition of Clinical Trials Contracts
Trending Stories
- As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer leaders play “musical chairs” as executive jobs fill at top cancer centers
Lee replaces Pisters at MD Anderson, Tuveson moves to Duke, and Mitchell is named director at University of Florida - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill









